Cargando…
Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review
OBJECTIVE: Evidence supporting the utility of pharmacogenetic (PGX) tests in depression is scarce. The main objectives of this study were to summarize, update, and assess the quality of the available evidence regarding PGX testing in depression as well as estimating the impact of using PGX testing t...
Autores principales: | Aboelbaha, Shimaa, Zolezzi, Monica, Elewa, Hazem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312313/ https://www.ncbi.nlm.nih.gov/pubmed/34321882 http://dx.doi.org/10.2147/NDT.S312966 |
Ejemplares similares
-
Mental Health Prescribers’ Perceptions on the Use of Pharmacogenetic Testing in the Management of Depression in the Middle East and North Africa Region
por: Aboelbaha, Shimaa, et al.
Publicado: (2023) -
“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020) -
Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022) -
Decision Support Tools for Regenerative Medicine: Systematic Review
por: Lam, Ching, et al.
Publicado: (2018) -
The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in
the MENA Region: A Systematic Review
por: Ali, Zainab, et al.
Publicado: (2019)